<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 1]
- [q-bio.QM](#q-bio.QM) [Total: 2]
- [cs.DS](#cs.DS) [Total: 1]
- [physics.comp-ph](#physics.comp-ph) [Total: 1]
- [cs.CL](#cs.CL) [Total: 1]
- [cs.AI](#cs.AI) [Total: 1]
- [cs.SE](#cs.SE) [Total: 1]
- [cs.LG](#cs.LG) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [Refined HLA Linkage Disequilibrium Architectures of World Populations by a Novel Allelic Correlation Measure](https://arxiv.org/abs/2512.05573)
*Fei Zhang,Weixiong Zhang*

Main category: q-bio.GN

TL;DR: 提出CICC新方法量化HLA连锁不平衡，发现多个跨人群共享的高LD区域，有助于疾病基因定位和精准医学。


<details>
  <summary>Details</summary>
Motivation: HLA区域与多种疾病相关，但现有LD测量方法无法充分捕捉其结构复杂性，受低频变异、边际等位基因频率和单倍型组成等因素限制。

Method: 提出条件信息相关系数(CICC)，整合条件概率、信息内容和单倍型感知的XOR逻辑，应用于HPRC、1000基因组计划和Genome Asia数据集。

Result: 在HLA中发现10个新的高LD区域，其中9个在五个全球人群中共享（5个在Class I，4个在Class II）。

Conclusion: CICC能有效捕捉跨人群的复杂HLA LD结构，在疾病基因定位、群体基因组学和指导精准医学方面具有广泛潜力。

Abstract: Numerous diseases, particularly autoimmune disorders, are associated with the human leukocyte antigen (HLA), a small genomic region located on human chromosome 6. Adequate characterization of linkage disequilibrium (LD) in the HLA across populations is crucial for identifying genetic markers associated with specific traits and phenotypes. However, current LD measures often fail to capture HLA's structural complexity due to methodological limitations and sensitivity to low-frequency variants, marginal allele frequencies, and haplotype composition. To address these challenges, we introduced the Conditional Informatics Correlation Coefficient (CICC), which integrates conditional probability, information content, and haplotype-aware XOR logic to quantify LD robustly. When applied to high-resolution haploid genomes from the Human Pangenome Reference Consortium (HPRC), CICC revealed 10 novel high-LD regions in HLA. Further analyses using the 1000 Genomes Project and Genome Asia datasets identified nine strongly linked regions shared across five global populations-five in Class I and four in Class II. These results demonstrate CICC's ability to capture complex HLA LD structures across populations, highlighting its broad potential for disease gene mapping, population genomics, and guiding precision medicine.

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [2] [Peakspan: Defining, Quantifying and Extending the Boundaries of Peak Productive Lifespan](https://arxiv.org/abs/2512.05208)
*Alex Zhavoronkov,Dominika Wilczok*

Main category: q-bio.QM

TL;DR: 论文提出"Peakspan"概念，指个体在特定生理或认知领域保持至少90%峰值功能表现的年龄区间，以弥补传统健康寿命指标的不足。


<details>
  <summary>Details</summary>
Motivation: 人类寿命延长需要新的指标来量化衰老质量和社会经济影响。传统健康寿命指标忽略了即使没有疾病情况下生理能力的逐渐衰退，导致生产力下降和工作能力丧失。

Method: 引入Peakspan概念，定义为个体在特定生理或认知领域保持至少90%峰值功能表现的年龄区间。通过多系统分析揭示生物系统功能变化模式。

Result: 研究发现大多数生物系统在成年早期达到最大能力，导致Peakspan相对于总寿命非常短暂。人类现在大部分成年生活处于"健康但功能衰退"状态。

Conclusion: 延长Peakspan和开发恢复峰值后个体功能的策略是再生医学进展的功能体现，对老龄化社会的持续经济增长至关重要。人工智能和衰老基础模型有助于跟踪Peakspan并制定压缩功能病态的策略。

Abstract: The unprecedented extension of the human lifespan necessitates a parallel evolution in how we quantify the quality of aging and its socioeconomic impact. Traditional metrics focusing on Healthspan (years free of disease) overlook the gradual erosion of physiological capacity that occurs even in the absence of illness, leading to declines in productivity and eventual lack of capacity to work. To address this critical gap, we introduce Peakspan: the age interval during which an individual maintains at least 90% of their peak functional performance in a specific physiological or cognitive domain. Our multi-system analysis reveals a profound misalignment: most biological systems reach maximal capacity in early adulthood, resulting in a Peakspan that is remarkably short relative to the total lifespan. This dissociation means humans now spend the majority of their adult lives in a "healthy but declined" state, characterized by a significant functional gap. We argue that extending Peakspan and developing strategies to restore function in post-peak individuals is the functional manifestation of rejuvenative biomedical progress and is essential for sustained economic growth in aging societies. Recognizing and tracking Peakspan, increasingly facilitated by artificial intelligence and foundational models of biological aging, is crucial for developing strategies to compress functional morbidity and maximize human potential across the life course.

</details>


### [3] [Physics-Guided Surrogate Modeling for Machine Learning-Driven DLD Design Optimization](https://arxiv.org/abs/2512.05649)
*Khayrul Islam,Mehedi Hasan,Yaling Liu*

Main category: q-bio.QM

TL;DR: 提出基于机器学习框架的DLD微流控芯片设计方法，通过仿真预测细胞机械特性与迁移行为关系，实现快速优化的设备设计


<details>
  <summary>Details</summary>
Motivation: 现有确定性侧向位移（DLD）设备设计依赖试错实验，对细胞尺寸和变形性敏感，需要更高效的设计方法

Method: 结合高精度粒子仿真模拟细胞变形和迁移，训练监督机器学习模型预测最优DLD几何结构，建立机械参数到变形指数和迁移角度的映射

Result: 开发了可部署的网页界面工具，实现数据驱动的DLD系统快速设计，为实际设备原型制作提供支持

Conclusion: 仿真驱动的机器学习框架能有效预测DLD设计参数，显著减少试错实验，加速基于细胞机械特性的分选设备开发

Abstract: Sorting cells based on their mechanical properties is essential for applications in disease diagnostics, cell therapy, and biomedical research. Deterministic Lateral Displacement (DLD) devices provide a label-free method for achieving such sorting, but their performance is highly sensitive to cell size and deformability. Designing effective DLD geometries often demands extensive trial-and-error experimentation, as even small variations in cellular mechanical traits can cause significant changes in migration behavior. To address this challenge, we propose a simulation-driven machine learning (ML) framework that predicts suitable DLD design candidates for a given cell type. Our approach integrates high-fidelity particle-based simulations to model cell deformation and migration through microfluidic pillar arrays with supervised ML models trained to estimate optimal geometries. By mapping mechanical parameters such as bending rigidity and shear modulus to deformation index and migration angle, the framework enables rapid, data-informed design of DLD systems. We also demonstrate a deployable web interface to make this tool accessible for real-world device prototyping.

</details>


<div id='cs.DS'></div>

# cs.DS [[Back]](#toc)

### [4] [Incorporating indel channels into average-case analysis of seed-chain-extend](https://arxiv.org/abs/2512.05247)
*Spencer Gibson,Yun William Yu*

Main category: cs.DS

TL;DR: 该论文将种子-链-延伸算法的理论分析扩展到包含插入和删除的突变通道，证明了最优链的期望恢复率至少为1-O(1/√m)，时间复杂度为O(mn^{3.15θ_T} log n)，其中θ_T < 0.159。


<details>
  <summary>Details</summary>
Motivation: 现有理论分析仅适用于纯替换突变通道，而实际基因组数据包含插入和删除(indels)。种子-链-延伸算法在实践中仍然有效，但理论与实际之间存在差距。需要建立能够处理indel通道的数学模型。

Method: 引入新的数学工具来处理indel通道带来的两个新挑战：相邻锚点的依赖关系，以及部分正确锚点的存在。通过分析这些因素，扩展了Shaw和Yu的理论框架。

Result: 证明了在总突变率θ_T = θ_i + θ_d + θ_s < 0.159的条件下，最优链的期望恢复率至少为1-O(1/√m)，期望运行时间为O(mn^{3.15θ_T} log n)。

Conclusion: 该研究成功将种子-链-延伸算法的理论分析扩展到包含插入和删除的突变通道，缩小了理论与实际应用之间的差距，为实际基因组数据分析提供了理论支持。

Abstract: Given a sequence $s_1$ of $n$ letters drawn i.i.d. from an alphabet of size $σ$ and a mutated substring $s_2$ of length $m < n$, we often want to recover the mutation history that generated $s_2$ from $s_1$. Modern sequence aligners are widely used for this task, and many employ the seed-chain-extend heuristic with $k$-mer seeds. Previously, Shaw and Yu showed that optimal linear-gap cost chaining can produce a chain with $1 - O\left(\frac{1}{\sqrt{m}}\right)$ recoverability, the proportion of the mutation history that is recovered, in $O\left(mn^{2.43θ} \log n\right)$ expected time, where $θ< 0.206$ is the mutation rate under a substitution-only channel and $s_1$ is assumed to be uniformly random. However, a gap remains between theory and practice, since real genomic data includes insertions and deletions (indels), and yet seed-chain-extend remains effective. In this paper, we generalize those prior results by introducing mathematical machinery to deal with the two new obstacles introduced by indel channels: the dependence of neighboring anchors and the presence of anchors that are only partially correct. We are thus able
  to prove that the expected recoverability of an optimal chain is $\ge 1 - O\Bigl(\frac{1}{\sqrt{m}}\Bigr)$ and the expected runtime is $O(mn^{3.15 \cdot θ_T}\log n)$, when the total mutation rate given by the sum of the substitution, insertion, and deletion mutation rates ($θ_T = θ_i + θ_d + θ_s$) is less than $0.159$.

</details>


<div id='physics.comp-ph'></div>

# physics.comp-ph [[Back]](#toc)

### [5] [Hypothesis-Based Particle Detection for Accurate Nanoparticle Counting and Digital Diagnostics](https://arxiv.org/abs/2512.05346)
*Neil H. Kim,Xiao-Liu Chu,Joseph B. DeGrandchamp,Matthew R. Foreman*

Main category: physics.comp-ph

TL;DR: 提出一种基于多重假设统计检验的纳米颗粒计数算法，用于数字分子诊断，无需训练数据或经验参数调优，在弱信号和复杂背景下保持鲁棒性。


<details>
  <summary>Details</summary>
Motivation: 数字检测技术能够精确检测低丰度分析物，对早期疾病诊断和个性化医疗至关重要。现有阈值或机器学习方法需要训练数据或经验参数调优，且结果可解释性有限。

Method: 基于显式图像形成模型，将纳米颗粒计数问题表述为多重假设统计检验，采用惩罚似然规则进行评估。该方法直接链接成像物理和统计决策理论，无需训练数据或经验参数调优。

Result: 数值模拟显示在弱信号、可变背景、放大倍数变化和适度PSF失配下保持鲁棒计数准确性。实验应用于SARS-CoV-2 DNA生物标志物检测的暗场图像，观察到对照组与阳性样本间颗粒计数分布的显著统计学差异。

Conclusion: 该方法为数字分子诊断中的纳米颗粒检测提供了可靠框架，结果可解释性强，能够洞察非特异性和靶标诱导的颗粒聚集现象。

Abstract: Digital assays represent a shift from traditional diagnostics and enable the precise detection of low-abundance analytes, critical for early disease diagnosis and personalized medicine, through discrete counting of biomolecular reporters. Within this paradigm, we present a particle counting algorithm for nanoparticle based imaging assays, formulated as a multiple-hypothesis statistical test under an explicit image-formation model and evaluated using a penalized likelihood rule. In contrast to thresholding or machine learning methods, this approach requires no training data or empirical parameter tuning, and its outputs remain interpretable through direct links to imaging physics and statistical decision theory.
  Through numerical simulations we demonstrate robust count accuracy across weak signals, variable backgrounds, magnification changes and moderate PSF mismatch. Particle resolvability tests further reveal characteristic error modes, including under-counting at very small separations and localized over-counting near the resolution limit. Practically, we also confirm the algorithm's utility, through application to experimental dark-field images comprising a nanoparticle-based assay for detection of DNA biomarkers derived from SARS-CoV-2. Statistically significant differences in particle count distributions are observed between control and positive samples. Full count statistics obtained further exhibit consistent over-dispersion, and provide insight into non-specific and target-induced particle aggregation. These results establish our method as a reliable framework for nanoparticle-based detection assays in digital molecular diagnostics.

</details>


<div id='cs.CL'></div>

# cs.CL [[Back]](#toc)

### [6] [Enhancing Clinical Note Generation with ICD-10, Clinical Ontology Knowledge Graphs, and Chain-of-Thought Prompting Using GPT-4](https://arxiv.org/abs/2512.05256)
*Ivan Makohon,Mohamad Najafi,Jian Wu,Mathias Brochhausen,Yaohang Li*

Main category: cs.CL

TL;DR: 使用思维链提示工程结合语义搜索和知识图谱，提升LLM生成临床病历的质量，减少医生手动记录时间。


<details>
  <summary>Details</summary>
Motivation: 电子健康记录数据激增，医生手动撰写临床病历耗时巨大，影响患者等待时间和诊断效率。LLM具有生成类人文本的能力，但需要专门优化以适应临床领域需求。

Method: 提出结合思维链提示工程、语义搜索和临床本体知识图谱的方法。输入ICD代码和患者基本信息，通过思维链引导LLM推理，利用语义搜索增强上下文，知识图谱注入领域专业知识。

Result: 在CodiEsp测试数据集的六个临床案例上使用GPT-4测试，该方法在生成临床病历质量方面优于标准单样本提示方法。

Conclusion: 思维链提示工程结合语义搜索和知识图谱能有效提升LLM生成临床病历的质量，为自动化临床文档生成提供有前景的解决方案。

Abstract: In the past decade a surge in the amount of electronic health record (EHR) data in the United States, attributed to a favorable policy environment created by the Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 and the 21st Century Cures Act of 2016. Clinical notes for patients' assessments, diagnoses, and treatments are captured in these EHRs in free-form text by physicians, who spend a considerable amount of time entering and editing them. Manually writing clinical notes takes a considerable amount of a doctor's valuable time, increasing the patient's waiting time and possibly delaying diagnoses. Large language models (LLMs) possess the ability to generate news articles that closely resemble human-written ones. We investigate the usage of Chain-of-Thought (CoT) prompt engineering to improve the LLM's response in clinical note generation. In our prompts, we use as input International Classification of Diseases (ICD) codes and basic patient information. We investigate a strategy that combines the traditional CoT with semantic search results to improve the quality of generated clinical notes. Additionally, we infuse a knowledge graph (KG) built from clinical ontology to further enrich the domain-specific knowledge of generated clinical notes. We test our prompting technique on six clinical cases from the CodiEsp test dataset using GPT-4 and our results show that it outperformed the clinical notes generated by standard one-shot prompts.

</details>


<div id='cs.AI'></div>

# cs.AI [[Back]](#toc)

### [7] [MCP-AI: Protocol-Driven Intelligence Framework for Autonomous Reasoning in Healthcare](https://arxiv.org/abs/2512.05365)
*Zag ElSayed,Craig Erickson,Ernest Pedapati*

Main category: cs.AI

TL;DR: MCP-AI是一种创新的医疗AI架构，将模型上下文协议（MCP）与临床应用结合，支持长期状态管理、可验证工作流和安全协作，相比传统临床决策支持系统和基于提示的LLMs有显著改进。


<details>
  <summary>Details</summary>
Motivation: 传统医疗AI系统在整合上下文推理、长期状态管理和人类可验证工作流方面存在挑战。随着医疗系统日益复杂，迫切需要自主、上下文感知的临床推理框架，以取代传统的临床决策支持系统和基于提示的大语言模型。

Method: 提出MCP-AI架构，基于模型上下文协议（MCP）构建可解释的医疗决策系统。MCP文件捕获临床目标、患者上下文、推理状态和任务逻辑，形成可重用和可审计的内存对象。系统支持自适应、纵向和跨护理环境的协作推理，并与HL7/FHIR接口连接，符合HIPAA和FDA SaMD等监管标准。

Result: 通过两个用例验证MCP-AI：(1) 脆性X综合征合并抑郁症的诊断建模；(2) 2型糖尿病和高血压的远程协调。该系统促进医生参与验证、简化临床流程，并保证AI责任在医疗提供者之间的安全转移。

Conclusion: MCP-AI为即将到来的临床环境提供了一个可扩展的基础，支持可解释、可组合和以安全为导向的AI，代表了医疗AI系统的重要范式转变。

Abstract: Healthcare AI systems have historically faced challenges in merging contextual reasoning, long-term state management, and human-verifiable workflows into a cohesive framework. This paper introduces a completely innovative architecture and concept: combining the Model Context Protocol (MCP) with a specific clinical application, known as MCP-AI. This integration allows intelligent agents to reason over extended periods, collaborate securely, and adhere to authentic clinical logic, representing a significant shift away from traditional Clinical Decision Support Systems (CDSS) and prompt-based Large Language Models (LLMs). As healthcare systems become more complex, the need for autonomous, context-aware clinical reasoning frameworks has become urgent. We present MCP-AI, a novel architecture for explainable medical decision-making built upon the Model Context Protocol (MCP) a modular, executable specification for orchestrating generative and descriptive AI agents in real-time workflows. Each MCP file captures clinical objectives, patient context, reasoning state, and task logic, forming a reusable and auditable memory object. Unlike conventional CDSS or stateless prompt-based AI systems, MCP-AI supports adaptive, longitudinal, and collaborative reasoning across care settings. MCP-AI is validated through two use cases: (1) diagnostic modeling of Fragile X Syndrome with comorbid depression, and (2) remote coordination for Type 2 Diabetes and hypertension. In either scenario, the protocol facilitates physician-in-the-loop validation, streamlines clinical processes, and guarantees secure transitions of AI responsibilities between healthcare providers. The system connects with HL7/FHIR interfaces and adheres to regulatory standards, such as HIPAA and FDA SaMD guidelines. MCP-AI provides a scalable basis for interpretable, composable, and safety-oriented AI within upcoming clinical environments.

</details>


<div id='cs.SE'></div>

# cs.SE [[Back]](#toc)

### [8] [Model Gateway: Model Management Platform for Model-Driven Drug Discovery](https://arxiv.org/abs/2512.05462)
*Yan-Shiun Wu,Nathan A. Morin*

Main category: cs.SE

TL;DR: Model Gateway是一个用于药物发现流程中管理和集成机器学习与科学计算模型的平台，支持LLM代理和生成式AI工具，实现模型注册、异步执行、动态共识等功能，可处理超过1万并发客户端，失败率为0%。


<details>
  <summary>Details</summary>
Motivation: 药物发现流程中需要管理大量机器学习模型和科学计算模型，传统方法难以高效集成、管理和执行这些模型，需要统一的平台来支持MLOps流程，加速药物开发。

Method: 开发了Model Gateway平台，包含模型所有者控制面板、平台管理工具和API服务，支持LLM代理和生成式AI工具，实现动态共识模型（聚合多个科学计算模型）、模型注册管理、异步提交执行和结果接收等功能。

Result: 平台在测试中能够处理超过1万同时应用客户端消费模型，失败率为0%，成为模型驱动药物发现流程的基础组成部分。

Conclusion: Model Gateway通过成熟的MLOps基础设施和LLM代理与生成式AI工具的集成，有潜力显著加速新药开发，是药物发现流程中的关键管理平台。

Abstract: This paper presents the Model Gateway, a management platform for managing machine learning (ML) and scientific computational models in the drug discovery pipeline. The platform supports Large Language Model (LLM) Agents and Generative AI-based tools to perform ML model management tasks in our Machine Learning operations (MLOps) pipelines, such as the dynamic consensus model, a model that aggregates several scientific computational models, registration and management, retrieving model information, asynchronous submission/execution of models, and receiving results once the model complete executions. The platform includes a Model Owner Control Panel, Platform Admin Tools, and Model Gateway API service for interacting with the platform and tracking model execution. The platform achieves a 0% failure rate when testing scaling beyond 10k simultaneous application clients consume models. The Model Gateway is a fundamental part of our model-driven drug discovery pipeline. It has the potential to significantly accelerate the development of new drugs with the maturity of our MLOps infrastructure and the integration of LLM Agents and Generative AI tools.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [9] [Mechanistic Interpretability of Antibody Language Models Using SAEs](https://arxiv.org/abs/2512.05794)
*Rebonto Haque,Oliver M. Turnbull,Anisha Parsan,Nithin Parsan,John J. Yang,Charlotte M. Deane*

Main category: cs.LG

TL;DR: TopK SAEs可识别抗体语言模型中的生物学特征，但特征相关性不等于因果控制；Ordered SAEs能可靠识别可操控特征但牺牲了可解释性。


<details>
  <summary>Details</summary>
Motivation: 研究稀疏自编码器在蛋白质语言模型中的机制可解释性，特别是如何用于理解抗体语言模型p-IgGen并操控其生成过程。

Method: 使用TopK和Ordered两种稀疏自编码器技术分析自回归抗体语言模型p-IgGen，比较它们在特征识别和生成操控方面的表现。

Result: TopK SAEs能揭示有生物学意义的潜在特征，但高特征概念相关性不能保证对生成的因果控制；Ordered SAEs能可靠识别可操控特征，但激活模式更复杂且可解释性降低。

Conclusion: TopK SAEs适用于将潜在特征映射到概念，而需要精确生成操控时应优先选择Ordered SAEs，这推进了领域特定蛋白质语言模型的机制可解释性。

Abstract: Sparse autoencoders (SAEs) are a mechanistic interpretability technique that have been used to provide insight into learned concepts within large protein language models. Here, we employ TopK and Ordered SAEs to investigate an autoregressive antibody language model, p-IgGen, and steer its generation. We show that TopK SAEs can reveal biologically meaningful latent features, but high feature concept correlation does not guarantee causal control over generation. In contrast, Ordered SAEs impose an hierarchical structure that reliably identifies steerable features, but at the expense of more complex and less interpretable activation patterns. These findings advance the mechanistic interpretability of domain-specific protein language models and suggest that, while TopK SAEs are sufficient for mapping latent features to concepts, Ordered SAEs are preferable when precise generative steering is required.

</details>
